Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel
Benjamin Thomas(Rheonix (United States)), Hayley C. Whitaker(University of Cambridge), Alastair Lamb(Queen Mary University of London), Marie Corcoran(Cancer Research UK), Hayley J. Luxton(Cancer Research UK), Greg Shaw(University College Hospital), Anne Y. Warren(Cambridge University Hospitals NHS Foundation Trust), Keith Burling(Cambridge University Hospitals NHS Foundation Trust), Laura J Bucklow(Cancer Research UK), Johanna Burge(Cancer Research UK), Suraj Menon(AstraZeneca (United Kingdom)), Charles Massie(University of Cambridge), Sara Stearn(Cancer Research UK), Sarah Dawson(Papworth Hospital NHS Foundation Trust), David E. Neal(University of Cambridge), Naomi L. Sharma(Addenbrooke's Hospital), Anne George(Cancer Research UK), Jonathan D. Kay(Cancer Research UK), Michelle Pugh(Cancer Research UK), Thomas J. Johnston(Cancer Research UK), Sarah L. Vowler(University of Cambridge), Peter Barker(Cambridge University Hospitals NHS Foundation Trust), Andy G. Lynch(University of St Andrews)
Cited by 13
Related Papers
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
The evolutionary history of lethal metastatic prostate cancer
|Nature|2015|1.4k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Multiple newly identified loci associated with prostate cancer susceptibility
|Nature Genetics|2008|850